92 related articles for article (PubMed ID: 2998083)
21. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
22. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
[TBL] [Abstract][Full Text] [Related]
23. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Thorac Cardiovasc Surg; 2005 Oct; 53(5):300-4. PubMed ID: 16208617
[TBL] [Abstract][Full Text] [Related]
24. Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2006; 26(5B):3845-8. PubMed ID: 17094411
[TBL] [Abstract][Full Text] [Related]
25. [Interleukin 3 (IL-3) in diagnosis and monitoring of non-small-cell lung cancer].
Mroczko B; Szmitkowski M; Czygier M
Przegl Lek; 1999; 56(12):763-6. PubMed ID: 10789186
[TBL] [Abstract][Full Text] [Related]
26. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
Di Martino G; Iannucci F; Bizzarro A; Iacono G
Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
[TBL] [Abstract][Full Text] [Related]
27. [Clinical factors and the ultrastructural characteristics of the tumor in the prognosis of small-cell lung cancer].
Glazkova TG; Smirnova EA; Ausekar B; Ogurtsova NA
Vopr Onkol; 1989; 35(2):207-14. PubMed ID: 2538968
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis, treatment, and prognosis of lung cancer in the Manche (France) (1997-1999) according to patients socioeconomic characteristics].
Madelaine J; Guizard AV; Lefevre H; Lecarpentier MM; Launoy G
Rev Epidemiol Sante Publique; 2002 Sep; 50(4):383-92. PubMed ID: 12442055
[TBL] [Abstract][Full Text] [Related]
29. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
[TBL] [Abstract][Full Text] [Related]
30. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
[TBL] [Abstract][Full Text] [Related]
31. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2005; 25(5):3601-5. PubMed ID: 16101187
[TBL] [Abstract][Full Text] [Related]
32. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal balance in women with lung cancer and its changes after combined treatment].
Tiutiunova AM; Chirvina ED; Mironenko TV; Kartashov SZ; Luntovskaia VA
Vopr Onkol; 1986; 32(4):26-30. PubMed ID: 3705523
[TBL] [Abstract][Full Text] [Related]
34. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
[TBL] [Abstract][Full Text] [Related]
35. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
[TBL] [Abstract][Full Text] [Related]
36. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
37. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
[TBL] [Abstract][Full Text] [Related]
38. [Parathyrin content of lung cancer patients undergoing surgical and chemotherapeutic treatment].
Afrikian MN; Tkacheva GA; Abramov VF
Med Radiol (Mosk); 1983 Apr; 28(4):31-3. PubMed ID: 6300611
[TBL] [Abstract][Full Text] [Related]
39. [Value of calcitonin and 6-oxo-prostaglandin Fl alpha in the differentiation of lung cancers].
Burghuber OC; Kovarik J; Woloszczuk W; Sehnal E; Sinzinger H; Weissel M
Acta Med Austriaca; 1987; 14(2):47-50. PubMed ID: 2820176
[TBL] [Abstract][Full Text] [Related]
40. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]